Companies / United Arab Emirates
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Foreign Drugmakers Exploiting IP Loophole?
November 2006 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
e CEO of UAE-based drugmaker Julphar, Abdul Razzaq Yousef, has called on the Ministry of Health to close what he calls a 'loophole' in the country's intellectual property laws that purportedly favours foreign drugmakers.